Efficacy and Safety of TrEating Type 2 Diabetic Patients With Inadequate Response to Metformin and DPP-4 Inhibitors by Adding Basal Insulin Therapy (Insulin Glargine)
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2015
Price : $35 *
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TED
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 26 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.